메뉴 건너뛰기




Volumn 52, Issue 2, 2013, Pages 183-186

Atypical hemolytic-uremic syndrome in a child presenting with malignant hypertension

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; HEMOGLOBIN; HEMOGLOBIN F; NICARDIPINE; NITROPRUSSIDE SODIUM;

EID: 84873364670     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922811412942     Document Type: Article
Times cited : (18)

References (15)
  • 1
    • 0035722282 scopus 로고    scopus 로고
    • Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
    • Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001 ; 60: 831-846
    • (2001) Kidney Int , vol.60 , pp. 831-846
    • Ruggenenti, P.1    Noris, M.2    Remuzzi, G.3
  • 3
    • 1842738527 scopus 로고    scopus 로고
    • Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome
    • Taylor CM, Chua C, Howie AJ, Risdon RA. Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome. Pediatr Nephrol. 2004 ; 19: 419-425
    • (2004) Pediatr Nephrol , vol.19 , pp. 419-425
    • Taylor, C.M.1    Chua, C.2    Howie, A.J.3    Risdon, R.A.4
  • 5
    • 61549117207 scopus 로고    scopus 로고
    • Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
    • Ariceta G, Besbas N, Johnson S, et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009 ; 24: 687-696
    • (2009) Pediatr Nephrol , vol.24 , pp. 687-696
    • Ariceta, G.1    Besbas, N.2    Johnson, S.3
  • 7
    • 33747159590 scopus 로고    scopus 로고
    • Genetics of HUS: The impact of MCP, CFH, and if mutations on clinical presentation, response to treatment, and outcome
    • Caprioli J, Noris M, Brioschi S, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006 ; 108: 1267-1279
    • (2006) Blood , vol.108 , pp. 1267-1279
    • Caprioli, J.1    Noris, M.2    Brioschi, S.3
  • 8
    • 34547633064 scopus 로고    scopus 로고
    • Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome
    • Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007 ; 18: 2392-2400
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2392-2400
    • Sellier-Leclerc, A.L.1    Fremeaux-Bacchi, V.2    Dragon-Durey, M.A.3
  • 9
    • 0032950690 scopus 로고    scopus 로고
    • Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Role of factor H abnormalities
    • Noris M, Ruggenenti P, Perna A, et al. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J Am Soc Nephrol. 1999 ; 10: 281-292
    • (1999) J Am Soc Nephrol , vol.10 , pp. 281-292
    • Noris, M.1    Ruggenenti, P.2    Perna, A.3
  • 10
    • 49349112382 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome recurrence after renal transplantation
    • Loirat C, Fremeaux-Bacchi V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant. 2008 ; 12: 619-629
    • (2008) Pediatr Transplant , vol.12 , pp. 619-629
    • Loirat, C.1    Fremeaux-Bacchi, V.2
  • 11
    • 67650102303 scopus 로고    scopus 로고
    • Pediatric approach to hypertension
    • Brady TM, Feld LG. Pediatric approach to hypertension. Semin Nephrol. 2009 ; 29: 379-388
    • (2009) Semin Nephrol , vol.29 , pp. 379-388
    • Brady, T.M.1    Feld, L.G.2
  • 13
    • 46949105006 scopus 로고    scopus 로고
    • Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations
    • Lapeyraque AL, Wagner E, Phan V, et al. Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations. Pediatr Nephrol. 2008 ; 23: 1363-1366
    • (2008) Pediatr Nephrol , vol.23 , pp. 1363-1366
    • Lapeyraque, A.L.1    Wagner, E.2    Phan, V.3
  • 14
    • 65649106258 scopus 로고    scopus 로고
    • Liver-kidney transplantation to cure atypical hemolytic uremic syndrome
    • Saland JM, Ruggenenti P, Remuzzi G. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2009 ; 20: 940-949
    • (2009) J Am Soc Nephrol , vol.20 , pp. 940-949
    • Saland, J.M.1    Ruggenenti, P.2    Remuzzi, G.3
  • 15
    • 59449107473 scopus 로고    scopus 로고
    • Eculizumab for atypical hemolytic-uremic syndrome
    • Nürnberger J, Philipp T, Witzke O, et al. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009 ; 360: 542-544
    • (2009) N Engl J Med , vol.360 , pp. 542-544
    • Nürnberger, J.1    Philipp, T.2    Witzke, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.